|
|
Do you deliver care to people who use opioids?
We Want Your Opinion.
Mainstay is a team of designers, health care professional and non-profit workers who are working together to create a space for people to go after they have been discharged form the emergency room for an overdose.
The aim of this research is to learn about your experience caring for people who have used or use opioids, from a team composition, therapeutic intervention, and physical space perspective.
Learn more about the participant study here.
Learn more about mainstay here.
|
|
|
Dr. Nicole Weiss, PhD, is an Assistant Professor in the Department of Psychology at the University of Rhode Island and Director of the Study of Trauma, Risk-taking, Emotions, and Stress Symptoms (STRESS) Lab. Dr. Weiss’ COBRE pilot project will use smartphone technology to track changes in patients post-traumatic stress disorder (PTSD) symptoms and substance use over extended time periods to identify the specific contexts and times in which people with PTSD are more likely to use substances. The primary goal of the project is to optimize detection and intervention of substance use among individuals with posttraumatic stress disorder. The findings will be instrumental to future studies on posttraumatic stress disorder and opioid misuse, with the goal of informing future interventions that more effectively address both posttraumatic stress disorder and opioid misuse.
To learn more about Dr. Weiss's COBRE Pilot Project, please watch this short video.
|
|
Postdoctoral Research Associate in Substance Use Epidemiology
Public Health, is hiring a full-time Postdoctoral Research Associate.The research team led by Dr. Brandon DL Marshall, Associate Professor of Epidemiology at Brown School of
The position is full-time, affiliated with the Department of Epidemiology, and is supported by several research grants. This is an exciting opportunity to be involved in a number of ongoing clinical trials, mathematical modeling studies, and analyses of overdose surveillance data collected by Rhode Island state agencies and analyzed by members of my research team. The successful applicant will lead and assist in the publication of study findings resulting from these ongoing projects.
Interested applicants can contact Dr. Marshall (brandon_marshall@brown.edu) directly and submit applications at https://apply.interfolio.com/81876. Required and preferred qualifications include:
- A PhD, ScD, or DrPH degree in epidemiology or a related field in public health.
- Significant research experience as evidenced by peer-reviewed publications.
- Demonstrated interest in substance use epidemiology, overdose prevention, opioid use disorder, and/or harm reduction interventions is required.
- Prior experience working with people who use drugs is preferred.
- Persons with a strong background in project management, rigorous training in epidemiological methods (e.g., geospatial analyses, longitudinal data analysis) and/or clinical trials is highly desired.
The position is for a minimum of one-year with the expectation of renewal. The preferred start date is June 1st, 2021; however, an earlier start date can be negotiated. Salary is competitive and commensurate with experience. The position includes a competitive full-time benefits package. Brown University is an EEO/AA employer. Review of applications will begin immediately and will continue until the position is filled or the search is closed. Candidates should apply with a cover letter (summarizing research experience, qualifications, and career goals), curriculum vitae, sample publication or equivalent, and the names and contact information for three references. People from historically under-represented backgrounds are particularly encouraged to apply!
Learn More Here
|
|
|
Congratulations!
Jesse Yedinak, the COBRE's Data and Research Methods Core Manager has been appointed to the position of Assistant Professor of the Practice of Epidemiology. In this new role, Jesse will have the opportunity to build out her own research agenda focused on collaboration with state agency and community partners.
Jesse has a Master of Public Administration (MPA) from the University of Colorado, Denver. She began her career at Brown University as a project manager in Dr. Brandon Marshall's Lab in 2014. Prior to moving to Rhode Island, she was a director at the Colorado AIDS Project, one of the largest HIV/AIDS service organizations in the Midwest. Jesse has an outstanding research record, having published or co-authored 18 peer-reviewed articles since 2014. Her 2019 first author publication in PLoS Medicine received widespread attention, and is exemplar of her highly collaborative approach to research with our state agency partners.
Congratulations Jesse, the COBRE is very fortunate to have you as part of our Team.
|
|
Int'l Network on Hepatitis in Substance Users (INHSU)
February virtual events focused on hepatitis C and the health of people who use drugs in prison
|
2/16, 3/2, 31616, 4/6, 5/4
Download Flyer Here
|
|
Virtual Implementation Science Seminar Series
Brown University's Dept. of Psychiatry and Human Behavior (DPHB)
|
February 9 and 24th
Download flyer here
|
|
Pandemic Problem S-Solving: Surviving and Thriving in the Age of Pandemics
Brown University School of Public Health
Dr. Ashish Jha and Dr. Megan Ranney
|
February 16 to March 25
Learn more & Register
|
|
Qualitative Methods Series
Advance-CTR
|
February 17 - Design Thinking
February 24 - Rapid Ethnography
March 3 - Concept Mapping
11:00 AM - 12:30 pm
Register Here
|
|
Virtual COVID-19 Response Innovation Hackathon
NEMIC
|
March 12-14 and/or April 16-18
Download Flyer Here
|
|
Medication-assisted Treatment for Opioid Use Disorder in Rhode Island
COBRE Lecture Series
|
|
The training will be held virtually over six sessions (9 hours total). Participants must commit to all six sessions:
- Monday, April 5 | 3-5 pm: Welcome & Introduction, Effective Communication
- Monday, April 12 | 3-4:15 pm: Aligning Expectations
- Monday, April 19 | 3-4:15 pm: Assessing Understanding
- Monday, April 26 | 3-4:15 pm: Fostering Independence
- Monday, May 3 | 3-4:15 pm: Addressing Equity & Inclusion
- Monday, May 10 | 3-5 pm: Promoting Professional Development, Articulating Your Mentoring Philosophy and Plan, Mentoring Resources
|
|
|
For a list of upcoming COBRE, National and local events and webinars, visit the COBRE's Event page.
|
|
Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research
NOT-DA-21-013
Data science is an important cross-cutting research approach in the NIDA Strategic Plan and increasing the capacity of experts in data science for biomedical research of addiction is critical. The purpose of this Notice is to highlight NIDA's high-priority interest in receiving applications that will support training and career development in Big Data and Computational Science (i.e., Data Science) within the overall field of addiction research. Grants supported under this Notice can be from individuals at formative career stages or from established investigators proposing training programs that will support early career scientists. Individuals from diverse backgrounds, including those from groups historically underrepresented in the STEM fields, who wish to pursue further studies or careers in Big Data and Computational Science as it relates to addiction research are highly encouraged to apply.
|
|
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
NOT-DA-21-018
Syndemic (synergistic epidemic) is the aggregation of two or more, concurrent or sequential epidemics or disease clusters, interacting synergistically in a population, contributing to excess burden of disease and prognosis. The Severe Acute Respiratory Syndrome (SARS)-coronavirus (CoV)-2 is responsible for a new coronavirus disease-19 (COVID-19). SARS-CoV-2 affects a wide variety of organs, among them the central nervous system (CNS). In parallel, HIV-1 is known to have significant neurotropic properties which can lead to HIV-associated neurocognitive disorders (HAND), classified according to its severity in asymptomatic, mild, or severe (HIV-dementia).
Individuals with Substance Use Disorders (SUDs), especially those who inject drugs (PWID), are at high risk of developing HIV, with notorious morbidity and mortality rates. HIV and SUDs are well-known factors for neurocognitive impairment. The first wave of the U.S. COVID-19 pandemic impacted urban areas where both the HIV and SUDs epidemics are prominent. In this vein, COVID-19 CNS alterations in survivors have been reported in about 30% of patients who required hospitalization. Symptoms include anosmia, loss of taste, loss of hearing, headaches, mental “fogginess”, confusion, fatigue, dizziness, and in severe cases encephalopathy. Long-term neurocognitive aspects of COVID-19 are likely but still not fully understood. Thus, it is of major public health relevance to study the long-term neurocognitive consequences of the COVID-19, HIV and SUD’s syndemic, given the combined viral neurotropism of SARS-CoV-2, HIV-1, and the deleterious effects of SUDs in the brain.
|
|
|
For a list of federal and government related opioid and substance misuse related funding opportunities, visit here.
|
|
|
|
